Boston, April 22, 2025 (GLOBE NEWSWIRE) — BCC Research reveals in its new report, High Content Screening/Imaging: Technologies and Global Markets, the HCS/I market is projected to reach $5.1 billion by 2029, at a five-year compound annual growth rate (CAGR) of 8.4%. Increasing R&D budgets reflecting a growing focus on innovation, is propelling this market.
The report offers an in-depth analysis of the high-content screening/imaging (HCS/I) market, exploring its growth potential through the forecast period of 2024 to 2029. It covers market drivers, challenges, trends, competitive landscape and key player shares, along with insights into instruments, consumables, software, services, and applications like screening, target validation and toxicity studies. Regional and country-level breakdowns for North America, Europe, Asia-Pacific and the Rest of the World are also included, with market estimates from 2021 to 2029.
Industry facts
- HCS/I technology is increasingly applied in toxicity studies and neuroscience, with the use of 3D models for cancer and other diseases to enhance the understanding of disease physiology and drug impacts on cells.
- The adoption of AI tools and automation for image analysis is rapidly advancing in the industry.
Factors Driving the Market:
- Increasing R&D budgets: Increasing R&D budgets reflect a growing focus on innovation, enabling companies to develop new technologies, improve products, and stay competitive in the market. This trend drives advancements across industries and fuels economic growth.
- Technological advances in HCS/I: Technological advances in HCS/I, such as AI integration, automation, and 3D cell models, are improving the accuracy and efficiency of drug discovery and research. These innovations enable deeper insights into cellular behaviour and disease mechanisms.
Request a sample copy of High Content Screening/Imaging: Technologies and Global Markets
Report Synopsis
| Report Metric | Details |